Penn Postdocs in the News: Soomin Jeong, Postdoctoral Fellow, recognized by the American Stroke Association with the 2026 Stroke Basic Science Award
Penn Postdoctoral Fellow Soomin Jeong receives the 2026 Stroke Basic Science Award from the American Stroke Association
PHILADELPHIA, PA — Dr. Soomin Jeong, a postdoctoral researcher in the Department of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania, has been selected as a 2026 recipient of the Stroke Basic Science Award from the American Stroke Association, recognizing outstanding contributions to cerebrovascular research.
Dr. Jeong joined Penn after earning a bachelor’s degree in Cell and Molecular Biology from the University of Illinois Urbana-Champaign, a master’s degree in Biomedical Sciences from Seoul National University, and a Ph.D. in Neuroscience from the University of Wisconsin–Madison in 2024.
At Penn, she works in the laboratory of Vladimir R. Muzykantov, MD, PhD, where her research centers on targeted therapeutic strategies to restore vascular function and improve recovery following stroke. Her work integrates systems pharmacology and precision delivery approaches to address injury at the blood–brain barrier and mitigate long-term neurological damage.
Her award-winning research highlights a novel therapeutic platform designed to restore the integrity of the blood–brain barrier after stroke using targeted mRNA nanoparticle delivery. By advancing strategies that promote vascular repair and functional recovery, Dr. Jeong’s work contributes to the development of next-generation stroke therapies.
The Stroke Basic Science Award honors exceptional laboratory-based research presented at the American Stroke Association’s International Stroke Conference. Recipients are recognized for scientific excellence, innovation, and potential impact on the prevention and treatment of stroke.
We are proud to host Dr. Jeong at Penn and celebrate this recognition, which reflects both her scientific achievements and Penn’s leadership in systems pharmacology and translational therapeutics research.